Literature DB >> 16899588

Antisense to cyclin D1 inhibits VEGF-stimulated growth of vascular endothelial cells: implication of tumor vascularization.

Richard G Pestell1, Zhiping Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16899588     DOI： 10.1158/1078-0432.CCR-06-0614

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

Authors:  Peijun Liu; Jining Lu; Wellington V Cardoso; Cyrus Vaziri
Journal:  Mol Biol Cell       Date:  2007-11-07       Impact factor: 4.138

2.  DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.

Authors:  Qian Chu; Na Han; Xun Yuan; Xin Nie; Hua Wu; Yu Chen; Mingzhou Guo; Shiying Yu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2014-10-17       Impact factor: 17.388

3.  Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.

Authors:  Francesco Marampon; Giovanni Gravina; Xiaoming Ju; Antonella Vetuschi; Roberta Sferra; Mathew C Casimiro; Simona Pompili; Claudio Festuccia; Alessandro Colapietro; Eugenio Gaudio; Ernesto Di Cesare; Vincenzo Tombolini; Richard G Pestell
Journal:  Oncotarget       Date:  2016-02-02

4.  LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.

Authors:  Yao Liu; Li-Li Wang; Shuo Chen; Zhi-Hong Zong; Xue Guan; Yang Zhao
Journal:  J Cell Mol Med       Date:  2018-05-25       Impact factor: 5.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.